Quality of life in allergic rhinitis patients treated with intralymphatic immunotherapy (ILIT): A 19-year follow-up

BACKGROUND: In 2002-2005, we conducted a phase I/II clinical trial where a new allergy immunotherapy (AIT) route was introduced: intralymphatic immunotherapy (ILIT). Ultrasound guidance allowed injection of allergen directly into inguinal lymph nodes. Grass pollen–allergic patients received 3 inject...

Descripción completa

Detalles Bibliográficos
Autores principales: Adlany, Yasmin K., Šošić, Lara, Senti, Gabriela, Lang, Claudia C.V., Wüthrich, Brunello, Kündig, Thomas M., Johansen, Pål
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509981/
https://www.ncbi.nlm.nih.gov/pubmed/37780115
http://dx.doi.org/10.1016/j.jacig.2022.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509981/
https://www.ncbi.nlm.nih.gov/pubmed/37780115
http://dx.doi.org/10.1016/j.jacig.2022.09.007

Ejemplares similares